Apr Positive News Today

British drug major AstraZeneca Plc. (AZN.L, AZN) announced Friday that the U.S. Food and Drug Administration or FDA has approved its Truqap (capivasertib) in combination with Faslodex (fulvestrant) to treat patients with advanced hormone receptor or HR-positive breast cancer.

Jane Lowe Meisel, MD, discusses previously reported data from the ELAINE-1 and ELAINE-2 trials, their significance within the ESR1-mutant, ER-positive, HER2-negative breast cancer treatment paradigm, and the purpose of the ongoing ELAINE-3 trial.

America after all is a beacon of freedom what better insurance than america to protect freedom on the internet, not to mention as brad argues here, our security. >> first after all, its absolutely fantasy to think that we actually control this. other countries are going to come up with their.c ss. why dont we take the pr positive of it and say that were goes to make it free and share through the united nations and know what we cant do anyhow which isa we cant control it. >> dont you worry about ...